Antibody Immunity against Emerging Pathogens
A special issue of Vaccines (ISSN 2076-393X). This special issue belongs to the section "Pathogens-host Immune Interface".
Deadline for manuscript submissions: 31 January 2025 | Viewed by 756
Special Issue Editors
Interests: infectious diseases; immunology; neuroimmunology; aging; autoimmunity
Special Issue Information
Dear Colleagues,
Emerging infections are a global health concern, and antibodies produced by the body fight invading pathogens. Antibodies have different mechanisms, can be antigen-specific, and are used to evaluate immune statuses. However, antibodies can also exacerbate disease severity and hinder vaccine development. This Special Issue aims to explore and understand the roles of antibodies in emerging and re-emerging viral infections, including profiling humoral responses, protective mechanisms, molecular mechanisms, improved strategies, therapeutic advances, and cross-reactive immunity.
The purpose of this Special Issue is to investigate and comprehend the role of antibodies in the context of emerging and re-emerging infections. The objective is to delve into the following aspects in detail:
- Characterization of humoral responses during viral, bacterial or fungal infections.
- Identification of new protective mechanisms of antibodies during acute and chronic infections.
- Study of the molecular mechanisms of autoantibodies that worsen microbial infections.
- Advancements in strategies to elicit antibody responses through vaccination.
- Recent developments in therapeutic antibodies against microbial infections.
- Analysis of cross-reactive immunity following infection and vaccination.
Dr. Fok Moon Lum
Dr. Siew-Wai Fong
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- antibodies
- autoantibodies
- natural antibodies
- autoimmunity
- pathogenesis
- humoral immunity
- vaccination
- diagnostic
